Karen A Dawes insider trades

Open-market stock purchases and sales by Karen A Dawes, Director at Barinthus Biotherapeutics plc., from SEC Form 4 filings since Sep 11, 2009.

Recent trades

DateStockTradeValue
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
Sep 9, 2026BRNS Barinthus Biotherapeutics plc.Sold (not open market)—
May 14, 2026RGEN Repligen CorpBought (not open market)—
May 14, 2026RGEN Repligen CorpBought (not open market)—
Dec 17, 2025RGEN Repligen CorpSold$44.3K

Companies traded

  • BRNS Barinthus Biotherapeutics plc.: other filings, last Sep 9, 2026
  • RGEN Repligen Corp: 5 buys, 91 sales, last May 14, 2026
  • VACC Vaccitech plc: 1 buy, last May 11, 2023
  • ASRT Assertio Therapeutics, Inc: 3 sales, last May 8, 2020
  • DEPO Depomed Inc: 2 buys, last May 8, 2018

Get free alerts when Karen A Dawes files a new trade →